High-grade Serous Cancer

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-01-17
Clinical Trial Update: Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor [Phase 2]
Phase 2 clinical trial evaluating a genetic profile–guided treatment strategy for ovarian cancer patients who previously received a PARP inh…